NCT05537922View on ClinicalTrials.gov

I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy

RecruitingOBSERVATIONAL
Enrollment

2,200

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

October 1, 2025

Study Completion Date

October 1, 2027

Conditions
Non Small Cell Lung CancerLung Cancer MetastaticLung Cancer, Nonsmall CellLung Adenocarcinoma
Trial Locations (4)

60637

RECRUITING

University of Chicago, Chicago

Unknown

RECRUITING

Metropolitan Hospital, Athens

RECRUITING

Shaare Zedek Medical Center, Jerusalem

RECRUITING

Vall D'Hebron Institute of Oncology, Barcelona

All Listed Sponsors
collaborator

Vall d'Hebron Institute of Oncology

OTHER

collaborator

Shaare Zedek Medical Center

OTHER

collaborator

LungenClinic Grosshansdorf

OTHER

collaborator

Metropolitan Hospital, Athens

UNKNOWN

collaborator

University of Chicago

OTHER

lead

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

OTHER

NCT05537922 - I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy | Biotech Hunter | Biotech Hunter